000			02033nai a2200481 i 4500
999			_c288296 _d288296
001			on1119736427
003			OCoLC
005			20191023093957.0
006			m o d f
007			cr mn|||||||||
008			190918c20189999dcu x w obb f0 2eng c
010			_a2019256610
040			_aPUCPR _beng _erda _epn _cGPO _dMvI
042			_apcc
043			_an-us---
074			_a0807-A-07 (online)
086	0		_aLC 14.23:R 44032/
099			_aLC 14.23:R 44032/
100	1		_aThomas, John R.,
245	1	0	_aPatents and regulatory exclusivities : _bissues in pharmaceutical innovation and competition / _cJohn R. Thomas.
250			_a[Library of Congress public edition].
264		1	_a[Washington, D.C.] : _bCongressional Research Service, _c[2018?]-
300			_a1 online resource.
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
490	1		_aReport / Congressional Research Service ; _vR44032
500			_aThe CRS report home page provides access to all versions published since 2018 in accordance with P.L. 115-141; earliest version dated [2015].
500			_aCRDP Program record.
504			_aReport includes bibliographical references.
588			_aDescription based on contents viewed on September 18, 2019; title from CRS report home page.
710	2		_aLibrary of Congress. _bCongressional Research Service,
773	0	8	_iContained in (work): _tCRS reports (Library of Congress. Congressional Research Service) _w(DLC) 2018231131 _w(OCoLC)1052784408
830		0	_aCRS report ; _vR44032.
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo125848
610	1	0	_aUnited States. _tDrug Price Competition and Patent Term Restoration Act of 1984.
650		0	_aPharmaceutical policy _zUnited States.
650		0	_aDrugs _zUnited States _xPatents.
650		0	_aPharmaceutical industry _zUnited States.
650		0	_aDrug development _zUnited States.
650		0	_aPatent laws and legislation _zUnited States.
942			_2sudocs _c8